<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Seventeen patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease were treated with intermittent intravenous bolus injections of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Twelve patients had severe eye lesions, 7 had central <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> and 2 had both ocular and central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> was given during 4 weeks on average, in mean doses of 922 +/- 127 mg </plain></SENT>
<SENT sid="3" pm="."><plain>Each patient received an average of 10 +/- 5 injections </plain></SENT>
<SENT sid="4" pm="."><plain>The drug was generally well tolerated; only one patient developed moderate and transient hepatocytolysis </plain></SENT>
<SENT sid="5" pm="."><plain>Visual acuity was improved in 12 of the 22 eyes with active lesions, and signs of <z:mp ids='MP_0001845'>inflammation</z:mp> disappeared in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="6" pm="."><plain>Neurological improvement was observed in 5 of the 7 patients affected, with complete regression of the disorders in 2 of them </plain></SENT>
<SENT sid="7" pm="."><plain>In 16 patients who were also under <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy, steroid dosage could be significantly reduced by 44 +/- 11 mg per day </plain></SENT>
</text></document>